Operating Lease, Right-of-Use Asset of Vivos Therapeutics, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vivos Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Vivos Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,383,000, a 200% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vivos Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,383,000 +$2,254,000 +200% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $3,244,000 +$2,027,000 +167% 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $951,000 -$351,000 -27% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,032,000 -$353,000 -25% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $1,129,000 -$337,000 -23% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $1,217,000 -$327,000 -21% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,302,000 -$319,000 -20% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,385,000 -$310,000 -18% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,466,000 -$662,000 -31% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,544,000 -$671,000 -30% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
Q1 2023 $1,621,000 +$107,000 +7.1% 31 Mar 2023 10-Q 08 Jun 2023 2023 Q1
Q4 2022 $1,695,000 31 Dec 2022 10-K/A 30 Jul 2024 2023 FY
Q3 2022 $2,128,000 30 Sep 2022 10-Q 20 Dec 2022 2022 Q3
Q2 2022 $2,215,000 30 Jun 2022 10-Q 20 Dec 2022 2022 Q2
Q1 2022 $1,514,000 31 Mar 2022 10-Q/A 25 Nov 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.